Using Spinal Cord Stimulators To Manage Central Post-stroke Pain Syndrome; When Multimodal Therapies Fail

Authors

Nitin Venkatesh, Oakland University William Beaumont School of Medicine Medical Student
Stephen Lau, Beaumont Health Resident
Rebecca R. Clemans, Beaumont Health

Document Type

Conference Proceeding

Publication Date

10-22-2022

Abstract

67 y.o. F w/ PMHx of HTN, well-managed T2DM, anxiety, and depression suffered from a right MCA stroke with residual left hemiplegia and persistent left-sided “burning” pain in body and face, diagnosed as Central Post-stroke Pain (CPSP) syndrome. The physically debilitating chronic neuropathic pain was refractory to multimodal management with pharmacologic agents (gabapentin, tramadol) and sympathetic nerve blocks (stellate ganglion, lumbar sympathetic). CPSP is challenging to treat and after exhausting alternative treatment options, a spinal cord stimulator (SCS) trial demonstrated significant pain improvement with eventual permanent implant. We discuss the pathophysiology of CPSP, indications, and benefits regarding use of SCS.

Comments

American Society of Anesthesiology Annual Meeting, New Orleans, LA, October 21-25, 2022.

Recommended Citation

Venkatesh N, Lau S, Clemans R. Using spinal cord stimulators to manage central post-stroke pain syndrome; when multimodal therapies fail. Presented at: American Society of Anesthesiology Annual Meeting; 2022 Oct 21-25; New Orleans, LA.